Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

63.94
+0.51000.80%
Volume:706.90K
Turnover:45.16M
Market Cap:7.97B
PE:-19.11
High:64.70
Open:63.46
Low:63.30
Close:63.43
52wk High:64.70
52wk Low:20.14
Shares:124.71M
Float Shares:119.55M
Volume Ratio:0.51
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3453
EPS(LYR):-3.5551
ROE:-4584.47%
ROA:-19.57%
PB:-26.10
PE(LYR):-17.99

Loading ...

Guardant Health Announces Promising Results from LIBERATE Study, Showcasing Guardant Reveal's Accuracy in Detecting Minimal Residual Disease in Early-Stage Breast Cancer

Reuters
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Zai Lab (ZLAB) and Guardant Health (GH)

TIPRANKS
·
Jun 06

Guardant Health Inc.'s CIO, Kumud Kalia, Reports Disposal of Common Shares

Reuters
·
Jun 06

Cathie Wood’s ARK Investment buys 99.6K shares of Guardant Health today

TIPRANKS
·
Jun 05

Director Meghan V. Joyce Reports Disposal of Guardant Health Inc. Common Shares

Reuters
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Hewlett Packard Enterprise, Venture Global

Reuters
·
Jun 04

Leerink Partners Remains a Buy on Guardant Health (GH)

TIPRANKS
·
Jun 03

FDA Grants Breakthrough Device Designation to Guardant Health's Shield Multi-Cancer Detection Test

Reuters
·
Jun 03

Cathie Wood’s ARK Investment buys 158.7K shares of Guardant Health today

TIPRANKS
·
Jun 03

BRIEF-Guardant Health Announced the results of the Serena-6 Phase III Trial

Reuters
·
Jun 02

Guardant Health's Phase III Trial Highlights Guardant360 CDx Test's Role in Early Detection of Therapy Resistance in Breast Cancer

Reuters
·
Jun 02

Guardant Health presented results of largest study on ctDNA in colon cancer

TIPRANKS
·
Jun 02

New Tests Promise to Reveal the Secrets in Your Blood -- Journal Report

Dow Jones
·
May 23

Guardant Health Launches Immunohistochemistry Testing for Solid Tumors

MT Newswires Live
·
May 22

Guardant Health Unveils Comprehensive IHC Testing for Enhanced Cancer Therapy Selection

Reuters
·
May 21

Director Tariq Musa Reports Disposal of Guardant Health Inc. Common Shares

Reuters
·
May 21

BRIEF-Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer

Reuters
·
May 20

Guardant Health Inc. Launches Hereditary Cancer Test to Improve Personalized Cancer Care and Risk Assessment

Reuters
·
May 20

GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating

TIPRANKS
·
May 10

GH Research Is Maintained at Buy by Guggenheim

Dow Jones
·
May 10